Most Recent
GSK, Novartis agree to $4.5M penalty for misleading Osteo Gel claims
Bird & Bird 2020-05-04 3:40 pm By Alison Eveleigh Sydney
GlaxoSmithKline and Novartis have agreed to a combined penalty of $4.5 million after the Australian Competition and Consumer Commission accused the pharmaceutical giants of making misleading claims in marketing their Voltaren Osteo Gel and Voltaren Emulgel pain relief products.
No harm, no foul? Full Court weighs ACCC challenge to flushable wipes ruling
ACCC 2020-02-24 5:58 pm By Miklos Bolza Sydney
The ACCC claims it was not required to prove Kimberly-Clark's flushable wipes caused actual harm to sewers, as it challenges a ruling that disposed of its consumer law case against the personal care giant.
Training college Unique cops $4M penalty in ACCC case
Australian Government Solicitor 2019-10-31 2:49 pm By Christine Caulfield Melbourne
Unique International College has been slapped with a $4.165 million penalty after a court found the defunct vocational trainer engaged in unconscionable conduct in enrolling students in courses costing up to $22,000.
Judge says sorry for delayed Osteo Gel judgment as penalty hearing set for 2020
Bird & Bird 2019-06-07 12:34 pm By Miklos Bolza Sydney
A Federal Court judge has apologised for "upsetting the applecart" and taking "too long" to publish his judgment in the consumer regulator's case against GlaxoSmithKline and Novartis over packaging for now discontinued painkiller Osteo Gel.